drugset / Trial / NCT04531748
Selective Estrogen Modulation and Melatonin in Early COVID-19
RandomizedParallel-groupQuadruple-blindTreatment
Summary
This study is a randomized, double-blind, controlled clinical trial to evaluate the effects of toremifene and/or melatonin in adults with mild COVID-19.
Timeline
- Start
- 2021-12
- Primary completion
- 2022-09
- Completion
- 2022-09
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Melatonin | Small molecule | 60 mg | — |
| Comparator | Toremifene | Small molecule | 60 mg | Oral |